Traditional antimalarials and the development of novel antimalarial drugs : Perspectives of ethnopharmacologyWRIGHT, Colin W.Journal of ethnopharmacology. 2005, Vol 100, Num 1-2, pp 67-71, issn 0378-8741, 5 p.Article

Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivativesLAVRADO, Joao; MACKEY, Zachary; HANSELL, Elizabeth et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 19, pp 6256-6260, issn 0960-894X, 5 p.Article

STUDIES ON MEDICINAL PLANTS OF SRI LANKA. III: PHARMACOLOGICAL IMPORTANT ALKALOIDS OF SOME SIDA SPECIESGUNATILAKA AAL; SOTHEESWARAN S; BALASUBRAMANIAM S et al.1980; PLANTA MED.; DEU; DA. 1980; VOL. 39; NO 1; PP. 66-72; BIBL. 18 REF.Article

THE ALPHA-ADRENOCEPTOR BLOCKING PROPERTIES OF CRYPTOLEPTINE ON THE RAT ISOLATED VAS DEFERENS: STUDIES ON CRYPTOLEPINENOAMESI BK; BAMGBOSE SOA.1980; PLANTA MED.; DEU; DA. 1980; VOL. 39; NO 1; PP. 51-56; BIBL. 11 REF.Article

Effects of the anti-malarial compound cryptolepine and its analogues in human lymphocytes and sperm in the Comet assayGOPALAN, Rajendran C; EMERCE, Esra; WRIGHT, Colin W et al.Toxicology letters. 2011, Vol 207, Num 3, pp 322-325, issn 0378-4274, 4 p.Article

Anti-inflammatory Properties of CryptolepineOLAJIDE, Olumayokun A; AJAYI, Abayomi M; WRIGHT, Colin W et al.PTR. Phytotherapy research. 2009, Vol 23, Num 10, pp 1421-1425, issn 0951-418X, 5 p.Article

The killing effect of cryptolepine on Staphylococcus aureusSAWER, I. K; BERRY, M. I; FORD, J. L et al.Letters in applied microbiology. 2005, Vol 40, Num 1, pp 24-29, issn 0266-8254, 6 p.Article

CRYPTOLEPINE HYDROCHLORIDE EFFECT ON STAPHYLOCOCCUS AUREUSKWABENA BOAKYE YIADOM; HEMAN ACKAH SM.1979; J. PHARM. SCI.; USA; DA. 1979; VOL. 68; NO 12; PP. 1510-1514; BIBL. 24 REF.Article

Synthesis and biological evaluation of analogues of cryptolepine, an alkaloid isolated from the Suriname rainforestYANG, S.-W; ABDEL-KADER, M; LANE, K et al.Journal of natural products (Print). 1999, Vol 62, Num 7, pp 976-983, issn 0163-3864Article

Submicro inverse-detection gradient NMR : A powerful new way of conducting structure elucidation studies with <0.05 μmol samplesMARTIN, G. E; GUIDO, J. E; ROBINS, R. H et al.Journal of natural products (Print). 1998, Vol 61, Num 5, pp 555-559, issn 0163-3864Article

The popular herbal antimalarial, extract of Cryptolepis sanguinolenta, is potently cytotoxicANSAH, Charles; GOODERHAM, Nigel J.Toxicological sciences (Print). 2002, Vol 70, Num 2, pp 245-251, issn 1096-6080, 7 p.Article

The effect of cryptolepine on the morphology and survival of Escherichia coli, Candida albicans and Saccharomyces cerevisiaeSAWER, I. K; BERRY, M. I; BROWN, M. W et al.Journal of applied bacteriology. 1995, Vol 79, Num 3, pp 314-321, issn 0021-8847Article

Antimalarial activity of cryptolepine and isocryptolepine, alkaloids isolated from Cryptolepis sanguinolentaGRELLIER, P; RAMIARAMANANA, L; MILLERIOUX, V et al.PTR. Phytotherapy research. 1996, Vol 10, Num 4, pp 317-321, issn 0951-418XArticle

Effects of cryptolepine on collagen-induced aggregation and on the mobilization and metabolism of arachidonic acid by rabbit plateletsOYEKAN, A. O; ABLORDEPPEY, S. Y.General pharmacology. 1993, Vol 24, Num 5, pp 1285-1290, issn 0306-3623Article

Genomewide Expression Profiling of Cryptolepine-Induced Toxicity in Saccharomyces cerevisiaeROJAS, Marta; WRIGHT, Colin W; PINA, Benjamin et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 11, pp 3844-3850, issn 0066-4804, 7 p.Article

Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine : Its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activitiesBIERER, D. E; FORT, D. M; PINGSHENG ZHANG et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 6, pp 894-901, issn 0022-2623Article

In vitro studies with liposomal cryptolepineSINGH, M; SINGH, M. P; ABLORDEPPEY, S et al.Drug development and industrial pharmacy. 1996, Vol 22, Num 4, pp 377-381, issn 0363-9045Article

STUDIES ON CRYPTOLEPINE. II: INHIBITION OF CARRAGEENAN INDUCED OEDEMA BY CRYPTOLEPINEBAMGBOSE SOA; NOAMESI BK.1981; PLANTA MED.; ISSN 0032-0943; DEU; DA. 1981; VOL. 41; NO 4; PP. 392-396; BIBL. 9 REF.Article

Indoloquinolines as Scaffolds for Drug DiscoveryLAVRADO, J; MOREIRA, R; PAULO, A et al.Current medicinal chemistry. 2010, Vol 17, Num 22, pp 2348-2370, issn 0929-8673, 23 p.Article

Cryptolepine-induced vasodilation in the isolated perfused kidney of the rat : role of G-proteins, K⁺ and Ca²⁺ channelsOYEKAN, A. O.European journal of pharmacology. 1995, Vol 285, Num 1, pp 1-9, issn 0014-2999Article

The mechanism(s) of the antiaggregatory effects of cryptolepine : the role of cyclic adenosine monophosphate and cellular Ca²⁺OYEKAN, A. O; ABLORDEPPEY, S. Y.General pharmacology. 1993, Vol 24, Num 2, pp 461-469, issn 0306-3623Article

Whole-body autoradiographic study on the distribution of ³H-cryptolepine in miceNOAMESI, B. K; LARSSON, B. S; LARYEA, D. L et al.Archives internationales de pharmacodynamie et de thérapie. 1991, Vol 313, pp 5-14, issn 0003-9780Article

Effects of cryptolepine alone and in combination with dipyridamole on a mouse model of arterial thrombosisOYEKAN, A. O; OKAFOR, J. P. O.Journal of ethnopharmacology. 1989, Vol 27, Num 1-2, pp 141-148, issn 0378-8741Article

Recombinagenic effect of cryptolepine in uvsH⁺//uvsH⁺ and uvsH//uvsH diploid strains of Aspergillus nidulansCHIUCHETTA, S. J. R; CASTRO-PMDO, M. A. A.Folia microbiologica. 2002, Vol 47, Num 5, pp 516-520, issn 0015-5632, 5 p.Article

DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepineBAILLY, Christian; LAINE, William; BALDEYROU, Brigitte et al.Anti-cancer drug design. 2000, Vol 15, Num 3, pp 191-201, issn 0266-9536Article